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G. R. BULLOCK*$ 
*Pharma Research, Ciba-Geigy AG, Basel, Switzerland and l-Hopital Arnaud de Villeneuve, Unique des 
Maladies Respiratoires, Montpellier, France 
Bronchial biopsies have made possible the detailed study of the pathology of the airways of humans with 
respiratory disease. Much data has been accumulated on asthmatics or normal controls but much less is 
known about chronic bronchitics. The aim of this study was to characterize the cellular and cytokine pattern 
seen in chronic bronchitics and to compare these with control and asthmatic subjects. The patients were also 
characterized clinically. In this study, immunocytochemistry on cryostat sections from bronchial biopsies were 
used to determine the level of inflammatory cells and cells of the immune system as well as the pattern of 
cytokines. This study revealed a distinct cellular and cytokine pattern for each of the three different patient 
groups, although the diversity of the cytokines analysed was limited by the size of the biopsies. In the 
inflammatory infiltrate of patients with asthma, CD4+ T-cells and eosinophils were the most prominent cell 
types discerned. All of the expected cytokines such as IL-I, TNF-a, IL-4, IL-5 and IFN-y were found. In 
contrast, the emphasis in chronic bronchitic patients was quite different. The predominant cell types were 
macrophages, neutrophils, mast cells and CD8 + T-cells, but eosinophils were also abundant. In addition, IL-4 
and TNF-a were the only cytokines present of those tested. 
Introduction 
Asthma and chronic bronchitis (CL!) are recog- 
nized as two diseases of the conducting airways 
which contribute significantly to morbidity and mor- 
tality world-wide (1). Until the advent of fibre-optic 
bronchoscopy, little was known about the mecha- 
nisms underlying asthma. Biopsy studies comparing 
the histology of patients with asthma with normal 
control subjects have demonstrated that an airway 
inflammatory process is present even in mild asth- 
matics (224) or in patients with newly-diagnosed 
asthma (5). In these studies, elevated numbers of 
eosinophils, activated lymphocytes and macrophages 
were constant features observed in asthmatics as 
compared with normal controls (3,4,(S). The num- 
bers of mast cells or neutrophils, however, did not 
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show significant changes in mild to moderate asth- 
matics as compared with normal subjects (7,9,10). 
Bronchial inflammation may be due in part to the 
release of cytokines by activated cells. Recent studies 
using in situ hybridization on bronchoalveolar lavage 
(BAL) cells and biopsies suggested that a THZlike 
cytokine pattern existed in asthma, with CD4+ 
T-cells being the major cytokine-producing cell type 
(11,12). In addition, an increase in the number of 
IL-5 mRNA positive cells could also be demon- 
strated in eosinophils from asthmatics (13), and mast 
cells have also been found to release cytokines in 
asthmatic airways (14). 
Inflammation is also known to be a feature of 
CB (1516). Neutrophils, macrophages and T-cells 
(17-19) but also eosinophils (20-22) have been found 
in the airways of patients with CB. The cytokine 
expression pattern in these CB patients has not yet 
been established in detail although TNF-a was found 
to be increased mainly during exacerbations (22). 
Judging by the assumed cause of this disease, it 
would be expected that a cytokine profile character- 
istic of chronic inflammation would be predominant, 
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Table I Demographic characteristics of the patients 
Patient No. Sex Age Aas* FEV, Smoking? Treatment1 
Asthmatics 
1 
2 
3 
4 
5 
6 
7 
8 9 
10 
11 
Chronic bronchitis 
12 
13 
14 
15 
16 
17 
Control subjects 
18 
19 
20 
21 
22 
M 31 
M 30 
F 45 
F 62 
F 21 
M 45 
M 39 
M 40 F 40 
M 36 
M 55 
M 53 
M 60 
M 63 
M 66 
M 71 
M 68 
F 39 
M 25 
M 35 
F 32 
M 45 
1 
1 
1 
2 
2 
2 
2 
3 3 
3 
3 
No 
No 
No 
No 
No 
78 
100 
100 
68 
100 
82 
100 
58 36 
46 
54 
70 
71 
66 
84 
50 
60 
100 
100 
n.d. 
105 
n.d. 
stop 5 
No 
? 
No 
No 
stop 20 
stop 10 
stop 15 No 
No 
No 
Smoking5 
40 
35 
40 
55 
100 
80 
No 
No 
No 
No 
No 
B 
None 
None 
None 
; 
; 
None 
P 
None 
None 
None 
None 
None 
*Aas, Asthma symptom score [grades of asthma on a scale from 1 (mild) to 5 (severe)] (35). 
tStop after x yr of smoking. #, p-agonist. scigarettes day- ‘. n.d., not determined. 
e.g. IL-l, IFN-y, IL-2 and TNF-a, but not IL-4 or 
IL-S. Again the eosinophil is present in large numbers 
but, in contrast to the asthmatic tissue, there is little 
suggestion of degranulation (20). 
In spite of their common inflammatory compo- 
nent, no direct comparison between asthma and CB 
in terms of cell and cytokine pattern has been carried 
out so far. The aim of this study was to characterize 
the most important cell types and cytokines in bron- 
chial biopsies derived from patients with these dis- 
eases and to compare them with healthy control 
subjects. By careful comparison with the clinical 
data, it was hoped that some insight might be gained 
which would contribute to the design of new specific 
drugs. In order to demonstrate the presence or 
absence of cells relevant to inflammation, immuno- 
cytochemistry was carried out on cryostat sections 
with markers for macrophages, mast cells, T-cell 
subsets, eosinophils, neutrophils and the cytokines 
IL-l, IFN-y, TNF-a, IL-4 and IL-S. GM-CSF was 
not studied as it has recently been shown that 
GM-CSF immunoreactivity was similar in CB and 
control biopsies (Vignola, unpubl. data) and also at a 
low level by comparison with asthma (23). 
Methods 
SUBJECTS 
Eleven patients with a well-documented history of 
asthma, six patients with CB and five healthy control 
subjects were chosen for this study. Their clinical 
characteristics are summarized in Table 1. The 
type of disease and status were carefully defined as 
previously described (20). 
FIBRE-OPTIC BRONCHOSCOPY 
Fibre-optic bronchoscopy was carried out as pre- 
viously described (4). The biopsy was removed under 
direct vision using alligator forceps in subsegmental 
bronchi of the left lower lobe. After excision of the 
tissue, the biopsy was frozen immediately and stored 
at - 80°C until transported to Basel, Switzerland on 
dry ice. The study was approved by the Ethics 
Committee of the hospital and subjects gave their 
informed consent. 
ANTIBODIES 
Murine monoclonal antibodies were purchased 
from Dakopatts (Glostrup, DK): CD68-DAKO- 
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Macrophage (M718) reacts with human macro- 
phages. DAKO-CD4 (MT 310) and -CD8 (DK 25) 
are specific for helper/inducer and suppressor/ 
cytotoxic T-cells, respectively. DAKO-Elastase 
(NP 57) is specific for human neutrophil elastase. 
Eosinophils were demonstrated with the mAb EGl 
to human eosinophilic cationic protein (ECP, Kabi 
Pharmacia, Duebendorf, Switzerland). This antibody 
recognizes both the stored and secreted forms of ECP 
(24). Mast cells were demonstrated with the mAb 
AA1 raised against human mast cell tryptase (25). 
The mAb 2D8 was used for the detection of IL-l/3 
(26). Its specificity was assessed using lipopolysaccha- 
ride (LPS) stimulated monocytes. For the detection 
of IL-4, the three mAbs 8F12, 4D9 and 3H4 raised 
against different epitopes of murine IL-4 were used as 
a cocktail. Their specificity was demonstrated on 
Chinese hamster ovary cells transfected with IL-4 
(27). IFN-1, was detected with the mAb 42-103 (28). 
The presence of IL-5 was revealed using the mAb 7 
which is specific for IL-5 (29). The anti-TNF-a 
polyclonal antibody was purchased from Genzyme 
(Cambridge, MA, U.S.A.). The rabbit anti-mouse 
antibody and the alkaline phosphatase anti-alkaline 
phosphatase (APAAP) complex were obtained 
from Jackson ImmunoResearch (West Grove, PA, 
U.S.A.). 
IMMUNOLABELLING 
The biopsies were mounted in Tissue Tek 5 Miles 
(Elkhart, IN, U.S.A.) and 8 pm cryosections were cut 
on a cryostat at - 22°C. Sections were picked up on 
a microscope slide, air-dried, wrapped in aluminium 
foil and stored at - 80°C until use. They’ were 
allowed to defrost before they were unwrapped for 
immunostaining. All steps were carried out at room 
temperature. Depending on the antigen, sections 
were fixed with either Tris-buffered saline (TBS: 
50 mM TrislHCI, pH 7.4, 0.15 NaCl) containing 2% 
formaldehyde (Polyscience, Warrington, PA, U.S.A.) 
for 20 min, or in 100% acetone (Fluka, Buchs, 
Switzerland) for 10min. After fixation, the slides 
were washed in TBS and non-specific binding sites 
and free Fey receptors were blocked with TBS con- 
taining 0.05% NP-40 (Pierce, Rockford, IL, U.S.A.), 
1% bovine serum albumin (BSA: Sigma, St Louis, 
MO, U.S.A.), 5% normal rabbit serum (NRS: Sera- 
Lab, Sussex, U.K.) and 5Opg ml ~ ’ human IgG 
(Jackson Immunoresearch) for 30 min. The primary 
antibodies were diluted in incubation buffer (TBS 
containing 0.05% NP-40, 1% BSA and 1% NRS) and 
applied to the section for 1 h. Sections were then 
washed with TBS/0.05% Tween 20 (Pierce) for 
3 x 10 min. Monoclonal antibody binding was 
detected by a modification of the APAAP method of 
Mason (30). Rabbit anti-mouse antibody diluted l/50 
in incubation buffer was applied for 30 min and the 
sections washed as above. The sections were then 
covered with the APAAP complex diluted l/50 in 
incubation buffer, incubated for 30 min and then 
washed as above. The rabbit anti-mouse and the 
APAAP steps were repeated once to increase signal 
intensity. Sections were finally washed in TrislHCl 
pH 8.2 and the alkaline phosphatase was developed 
using Fast Red as the chromogen, yielding a red 
precipitate (30). Levamisole (Sigma) was included in 
the colour reaction at a final concentration of 5 mM 
in order to block endogenous alkaline phosphatase 
(31). Sections were counterstained with Harris’ 
haematoxylin (Merck, Dietikon, Switzerland) for 5 s. 
Cell preparations were mounted in 90% glyceroYlO% 
H,O. Control slides were treated in the same way but 
omitting the primary antibody. 
Quantification of staining and analysis of results: 
Sections were examined using a Zeiss Axiophot 
microscope (Oberkochen, Germany). For patients 
with asthma, one section was examined for each 
antibody due to the very small size of the samples 
available. For patients with CB and healthy control 
subjects, at least two sections were analysed for each 
antibody. All the ratings for the staining was per- 
formed on coded sections by one investigator (GB) 
who was not aware of the status of the patient. 
Staining was assessed semi-quantitatively as follows: 
0, no; 1, weak staining; 2, moderate staining; 3, 
strong staining. This assessment of staining is closer 
to being logarithmic than linear. Very small sections 
could not be rated satisfactorily and had to be 
excluded. The accuracy of this quantification method 
had been verified in the mouse lung where detailed 
counts of positive cells per unit area were made using 
image analysis, and a direct comparison with the 
semi-quantitative method was made. 
STATISTICAL ANALYSIS AND EXPRESSION OF THE DATA 
Final data was expressed as means f SEM for pa- 
tients with asthma, CB and healthy control subjects. 
The Fischer exact test was used for comparisons. 
Results 
This biopsy study was carried out with a total of 
22 subjects: 11 asthmatics, six chronic bronchitics 
and five healthy control subjects. A mucosal inflam- 
matory infiltrate was observed in all subjects stud- 
ied. This infiltrate often demonstrated a pronounced 
concentration of cells beneath the epithelial base- 
ment membrane but was otherwise equally 
82 R. Mueller et al. 
m Macrophages a CD8+ T-cells 
m Mast cells m Eosinophils 
0 CD4+ T-cells H Neutrophils 
A CB N 
Patient group 
Fig. I Scoring of immunocytochemical staining for the 
different cell types present in cryostat sections from patients 
with asthma (A), chronic bronchitis (CB), and normal 
controls (N). Score: 0, no staining; 1, weak staining; 2, 
moderate staining; 3, strong staining. 
distributed throughout the whole tissue sample. A 
summary of all the biopsy finding can be seen in 
Figs 1 (cell types identified), 2 (positive cytokine 
signal) and 3 (percentage of patients with a positive 
signal. 
From Fig. 1, it can be seen that both asthmatics 
and patients with CB showed an increase in the 
number of macrophages, eosinophils and both 
CD4+ and CD8+ T-lymphocytes as compared with 
normal control subjects. Patients with CB showed an 
increase in the number of mast cells as compared 
with both asthmatic and normal control subjects, 
while the number of neutrophils was decreased in 
asthmatics as compared with patients with CB and 
normal control subjects. 
The presence of all five cytokines investigated 
(Fig. 2) could be detected in asthmatic patients, with 
IL-4 and IFN-y being predominant. In patients with 
CB, only IL-4 and TNF-a could be detected on 
occasion, and in normal control subjects both IL-4 
and IL-5 could be found but only rarely. 
The data was analysed using the Anova statistical 
system [Fischer PLSD (exact) test]. The small num- 
bers of samples prevented definitive statements being 
made but distinct trends were noted. Table 2 gives the 
results where a significant difference was seen, i.e. the 
increase in macrophages over control for both 
asthma and CB, and the increase in IL-4 positive cells 
in CB as compared with control. 
Figure 3 gives the incidence of the cytokines and 
Fig. 4 compares the individual scoring for cytokines 
and cell types found present in the different patient 
31 
m IL-lp m IL-4 
P 
B 
&j TNF-a m IFN-y 
-i 2 
0 IL-5 
+ 
0 
A CB N 
Patient group 
Fig. 2 Scoring of immunocytochemical staining for the 
different cytokines present in cryostat sections from patients 
with asthma (A), chronic bronchitis (CB), and normal 
controls (N). Scoring system see Fig. 1. 
Table 2 ANOVA analysis summary [all values are P 
values from the Fisher PLSD (exact) test] 
Asthma CB Normal 
Macrophages 
Asthma 
CB 
Normal 
IL-4 positive cells 
Asthma 
CB 
Normal 
IFN-7 positive cells 
Asthma 
CB 
Normal 
Neutrophils 
Asthma 
CB 
Normal 
CD4+ T-cells 
Asthma 
CB 
Normal 
CD8 + T-cells 
Asthma 
CB 
Normal 
- 
n.s. 
0.01 0.01 - 
- 
0.01 - 
0.05 n.s. 
- 
0.01 - 
0.05 n.s. 
- 
0.05 - 
ns. ns. 
- 
n.s. 
0.05 0.05 - 
- 
n.s. 
n.s. 0.05 - 
All values are P values from the Fischer PLSD (exact) test. 
CB, chronic bronchitis; n.s., not significant. 
groups. As always in these studies, a big variation 
within groups was observed. In all the sections, the 
presence of macrophages could be detected [Fig. 
4(a)]. Patients with CB showed a consistent increase 
in the number of macrophages as compared with 
healthy control subjects. In six of 11 patients with 
Cytokine pattern in asthma and chronic bronchitis 83 
IFN-7 IL-4 IL-5 TNF-a IL-lp 
Cytokine 
Fig. 3 Percentage of patients with asthma (solid bar), 
chronic bronchitis (stippled bar) and normal controls (open 
bar) in which a positive signal for the individual cytokines 
could be detected. 
asthma, the number of macrophages was increased 
when compared with normal subjects. IL-l/3 staining 
was seen in patients with asthma (3/l 1) but in neither 
of the other two study groups, despite the presence of 
large numbers of macrophages. TNF-a was detect- 
able in both patients with asthma (2/7) and CB (116). 
Control subjects showed no staining for this 
cytokine. 
The number of mast cells as seen by the presence of 
mast cell specific tryptase showed big variations 
between the different groups [Fig. 4(b)]. Overall, the 
average number was increased in patients with CB as 
compared with asthmatics and normal control sub- 
jects. Mast cells in biopsies from asthmatics often had 
a degranulated appearance. The presence of IL-4 was 
a consistent observation in subjects with asthma. 
Eight of 11 patients were positive for IL-4. These 
positive cells were mainly located close to the base- 
ment membrane. In patients with CB, one of six 
patients was IL-4 positive, and in healthy controls, 
one of five patients was IL-4 positive. 
Similar numbers of CD4+ T-lymphocytes were 
seen both in patients with asthma and CB.The aver- 
age numbers in these two groups were elevated as 
compared with control subjects. In patients with CB, 
a clear increase in the ratio of CD8+/CD4+ T-cells 
could be seen. IFN-y expression was confined to 
subjects with asthma, where four of nine patients 
were positive. This cytokine could not be detected in 
the other two groups (Fig. 3). 
Eosinophils were not seen in control subjects 
[Fig. 4(c)] although two of three normal controls 
were weakly positive for IL-5 suggesting the 
involvement of a different cell type. Both patients 
with asthma and CB showed considerable numbers 
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Fig 4 Individual scoring for cell types and cytokines in 
patients with asthma (A), chronic bronchitis (CB), and 
normal controls (N). Scoring system see Fig. 1. (a) Com- 
parison between macrophages (0), IL-l/? (0 and TNF-a 
(+); (b) comparison between mast cells (a), CD4+ T- 
lymphocytes (A) and IL-4 (0); and (c) comparison between 
eosinophils (m) and IL-5 ( x ). 
of eosinophils. Three of nine asthmatic patients 
were positive for IL-S while no IL-5 could be seen 
in CB patients. 
Patients with CB showed an increase in the number 
of neutrophils as compared with patients with 
asthma. Two of four normal controls showed high 
numbers of neutrophils as well. 
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Discussion 
As with any clinical study, the importance of 
careful characterization of the patient cannot be 
over-emphasized. Guidelines drawn up by the 
American Thoracic Society (32) were strictly adhered 
to and the parameters used have been established 
and thoroughly tested in previous studies (4,20). 
As can also be seen in Table 1, the clinical data 
for both patients and controls have been recorded 
and correlated with the findings from the biopsy 
samples. 
Obviously with bronchial biopsies, the amount of 
tissue obtained is very small, only allowing a limited 
number of sections to be cut from each one. In turn, 
this affects the choice of cytokine and cell markers 
that can be used. The cytokines chosen for study in 
the asthmatic patients were those already well estab- 
lished as being upregulated in asthma, with the 
exception of GM-CSF as mentioned earlier (23), as 
this part of the study was designed to confirm or 
extend data already obtained. The markers could be 
divided into two groups, those related to the immu- 
nological component e.g. T-cells, and those related to 
the inflammatory component e.g. macrophages or 
neutrophils. 
When investigating CB, the relevance of taking 
bronchial biopsies is justified by the knowledge that 
this is not a lower airway disease but, as with asthma, 
the bronchioles are likely to be strongly affected. 
When compared with the controls, it is clear that 
considerable changes have occurred particularly with 
regard to eosinophils which were not present in any 
of the five controls. The inflammatory infiltrate 
found in asthmatic and CB patients was similar in 
this study to results observed previously. In particu- 
lar, T-cells and macrophages as well as eosinophils 
were found in increased numbers in comparison with 
control subjects. Two of the controls had very high 
neutrophil counts even though they were non- 
smokers, and may have been in recent contact with 
some stimulatory agent. 
IL-5 was detected in some normal subjects and 
asthmatics, but was not detected in CB, although 
eosinophils were present in both asthmatics and CB. 
Although IL-5 immunoreactivity is not usually found 
in biopsies from normal subjects, the results of the 
present study are not related to the selection of 
the subjects who were not asthmatics nor allergic nor 
to the antibody used which was highly specific. More- 
over, as already reported, eosinophils did not appear 
to be degranulated in stable CB patients (20) and it is 
possible that the eosinophilic inflammation in this 
disease is not directly driven by IL-5. 
The most important new finding is the lack of IL-l/I 
and IFN-y in the CB patients, an observation that 
needs conformation in larger numbers of samples. 
Moreover, there were many more CD4+ and CD8 + 
cells compared with normal controls, particularly the 
latter, but at the same time there was no staining for 
IFN-y. In asthma, Thl-cytokines such as IFN-), were 
increased in bronchial biopsies and this finding might 
be surprising since a ThZlike response has been 
observed. However, this was more usually observed 
after allergen challenge which may drive the cytokine 
pattern towards a Th2-response (12,33). However, in 
stable asthmatics, it has been found that many T-cells 
were of the Thl or ThO phenotype in the airways (34). 
Patients in this study have been studied at steady 
state explaining the importance of IFN-7 immuno- 
reactivity. The low incidence of TNF-a accords with 
previous data on stable CB patients (21,22) and also 
adds to the strong suggestion that even though 
macrophages are ‘clearly present in large numbers, 
their inflammatory cytokines do not appear to be of 
great relevance in the disease process. On the con- 
trary, the high numbers of CD8+ T-cells warrants 
further investigation and a role for these cells needs 
to be further examined. 
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